TNFRSF12A expression in stomach adenocarcinoma and its preliminary role in predicting immunotherapy response
The present study not only reveals the potential of <i>TNFRSF12A</i> as a therapeutic target for STAD, but also explores its great potential in STAD immunotherapy. This finding opens up a new way of thinking for the personalized treatment of STAD.
Authors
- Linde Sun
- Xiaodong Yang (ORCID: https://orcid.org/0000-0001-7685-5011)
- Lin Liu (ORCID: https://orcid.org/0000-0002-1450-4950)
- Zelong Yang
- Jing Yao (ORCID: https://orcid.org/0000-0001-6999-0987)
- Linlin Zhang (ORCID: https://orcid.org/0000-0002-2644-4289)
- Junyan Liu (ORCID: https://orcid.org/0000-0002-8331-5117)
- Zheng Wan (ORCID: https://orcid.org/0000-0001-8455-3478)
Institutions
- Chinese PLA General Hospital (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-05
- DOI
- https://doi.org/10.3389/fimmu.2025.1578068
- Citations
- 1
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80